Showing 1 - 11 results of 11 for search 'Woo P', query time: 0.09s Refine Results
  1. 1
    Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret<sup>®</sup>) in systemic juvenile idiopathic arthritis

    Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret<sup>®</sup>) in systemic juvenile idiopathic arthritis by Livermore P, Woo P

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre

    Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre by Livermore P, Woodworth T, Woo P

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept

    An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept by Livermore P, Woo P, Wedderburn LR

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment

    Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment by Ogilvie EM, Samuel JM, Woo P

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

    Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth... by Hirani SP, Kassoumeri L, Mulligan K, Ruperto N, Woo P, Wedderburn LR, Newman SP

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

    Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA) by Hirani SP, Kassoumeri L, Etheridge A, Mulligan K, Ruperto N, Woo P, Wedderburn L, Newman SP

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)

    2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... by Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey

    Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey by Gattorno M, Frenkel J, Ozen S, De Benedetti F, Konè-Paut I, Neven N, Girschick H, Özdogan H, Wouters C, Woo P, Hofer M, Dolezalova P, Toplak N, Richard V, Martini A, Ruperto N

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

    2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme... by Ruperto N, Lovell DJ, Cuttica R, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

    Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data by Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, Zuber Z, Wulffraat N, Joos R, Dolezalova P, Burgos-Vargas R, Woo P, Schneider R, Ruperto N, Brunner H, De Benedetti F, Flato B, Gerloni V, Horneff G, Wright S, Kenwright A, Lovell D, Martini A

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment

    The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment by Touitou I, Woo P, Lachmann H, Dolezalova P, Rose C, Hentgen V, Wouters C, Vesely R, Stojanov S, Simon A, Arostegui J, Kummerle-Deschner J, Ozdogan H, Neven B, Girschick H, Kone-Paut I, Hofer M, De Benedetti F, Ozen S, Frenkel J, Toplak N, Martini A, Ruperto N, Gattorno M

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: